Literature DB >> 25957813

Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.

Nilza M Biaggi-Labiosa1, Emir Avilés-Pagán1, Daniel Caballero-Rivera2, Carlos A Báez-Pagán3, José A Lasalde-Dominicci4.   

Abstract

The α4β2 neuronal nicotinic acetylcholine receptor (nAChR) plays a crucial role in nicotine addiction. These receptors are known to desensitize and up-regulate after chronic nicotine exposure, but the mechanism remains unknown. Currently, the structure and functional role of the intracellular domains of the nAChR are obscure. To study the effect of subunit phosphorylation on α4β2 nAChR function and expression, eleven residues located in the M3-M4 cytoplasmic loop were mutated to alanine and aspartic acid. Two-electrode voltage clamp and 125I-labeled epibatidine binding assays were performed on Xenopus oocytes to assess agonist activation and receptor expression. When ACh was used as an agonist, a decrease in receptor activation was observed for the majority of the mutations. When nicotine was used as an agonist, four mutations exhibited a statistically significant hypersensitivity to nicotine (S438D, S469A, Y576A, and S589A). Additionally, two mutations (S516D and T536A) that displayed normal activation with ACh displayed remarkable reductions in sensitivity to nicotine. Binding assays revealed a constitutive up-regulation in these two nicotine mutations with reduced nicotine sensitivity. These results suggest that consensus phosphorylation residues in the M3-M4 cytoplasmic loop of the α4 subunit play a crucial role in regulating α4β2 nAChR agonist selectivity and functional expression. Furthermore, these results suggest that disruption of specific interactions at PKC putative consensus sites can render α4β2 nAChRs almost insensitive to nicotine without substantial effects on normal AChR function. Therefore, these PKC consensus sites in the M3-M4 cytoplasmic loop of the α4 nAChR subunit could be a target for smoking cessation drugs.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Nicotine; Nicotine sensitivity; Nicotinic acetylcholine receptor; Phosphorylation; Two-electrode voltage clamp

Mesh:

Substances:

Year:  2015        PMID: 25957813      PMCID: PMC4636472          DOI: 10.1016/j.neuropharm.2015.04.022

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  29 in total

Review 1.  Nicotinic acetylcholine receptors: from structure to brain function.

Authors:  R C Hogg; M Raggenbass; D Bertrand
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-03-20       Impact factor: 5.545

2.  The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs.

Authors:  Heejeong Kim; Brody A Flanagin; Chuan Qin; Robert L Macdonald; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2003-09       Impact factor: 5.250

3.  Cyclic AMP-dependent protein kinase (PKA) and protein kinase C phosphorylate sites in the amino acid sequence corresponding to the M3/M4 cytoplasmic domain of alpha4 neuronal nicotinic receptor subunits.

Authors:  L Wecker; X Guo; A M Rycerz; S C Edwards
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

4.  Downregulation of nicotinic receptor function after chronic nicotine infusion.

Authors:  M J Marks; S R Grady; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

5.  Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.

Authors:  R J Lukas
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

6.  Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc.

Authors:  Istvan Arany; Jeb Clark; Dustin K Reed; Luis A Juncos
Journal:  Nephrol Dial Transplant       Date:  2013-01-16       Impact factor: 5.992

7.  Protein kinase A regulates nicotinic cholinergic receptors and subunit messenger ribonucleic acids in PC 12 cells.

Authors:  T C Madhok; H S Beyer; B M Sharp
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

8.  Phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase in vitro.

Authors:  H Nakayama; H Okuda; T Nakashima
Journal:  Brain Res Mol Brain Res       Date:  1993-10

9.  Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.

Authors:  Mark E Nelson; Alexander Kuryatov; Catherine H Choi; Yan Zhou; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

10.  Nicotine-induced up-regulation and desensitization of alpha4beta2 neuronal nicotinic receptors depend on subunit ratio.

Authors:  Gretchen Y López-Hernández; Javier Sánchez-Padilla; Alejandro Ortiz-Acevedo; José Lizardi-Ortiz; Janice Salas-Vincenty; Legier V Rojas; José A Lasalde-Dominicci
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

View more
  3 in total

1.  Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.

Authors:  Sita Nirupama Nishtala; Nelli Mnatsakanyan; Akash Pandhare; Chun Leung; Michaela Jansen
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

2.  Tyrosine phosphorylation differentially fine-tunes ionotropic and metabotropic responses of human α7 nicotinic acetylcholine receptor.

Authors:  Juan Facundo Chrestia; Ariana Bruzzone; María Del Carmen Esandi; Cecilia Bouzat
Journal:  Cell Mol Life Sci       Date:  2021-05-24       Impact factor: 9.261

Review 3.  Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment.

Authors:  Wuyi Liu; Ming D Li
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.